We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Molecular Mechanism Identified That Enables Leukemia Cells to Evade Chemotherapy

By LabMedica International staff writers
Posted on 01 Feb 2012
Cancer researchers have identified a molecular mechanism used by acute myeloid leukemia (AML) cells to evade chemotherapy.

Investigators at the University of Colorado School of Medicine (Denver, USA) used novel molecular and computational approaches to perform genome-wide short-hairpin RNA screens to identify proteins that mediate the fate of AML cells after exposure to the drug cytarabine (cytosine arabinoside). More...
Gene expression profiling of AML cells exposed to cytarabine was carried out to identify genes with expression induced by the drug treatment. Such gene activity was compared to records of gene expression data from primary patient samples.

Results published in the January 13, 2012, online edition of the journal Leukemia strongly implicated cell-cycle checkpoint proteins, particularly WEE1, as critical mediators of AML cell survival after cytarabine exposure. Knockdown of WEE1 in a secondary screen confirmed its role in AML cell survival. Pharmacologic inhibition of WEE1 in AML cell lines and primary cells increased the potency of cytarabine.

Wee1 inhibits entry of cells into mitosis, and its absence leads to division at a premature stage and sub-normal cell size. Conversely, when Wee1 expression is increased, mitosis is delayed and cells grow to a large size before dividing. Further experiments conducted as part of the current study demonstrated that inhibition of WEE1 prevented S-phase arrest in AML cells induced by cytarabine, broadening the functions of WEE1 that may be exploited therapeutically.

“Introducing chemotherapy to cells is like putting a curve in front of a speeding car,” said first author Dr. Christopher Porter, assistant professor of pediatrics at the University of Colorado School of Medicine. “Cells that can put on the brakes make it around the corner and cells that cannot speed off the track. WEE1 is the brakes. With chemotherapy, we introduce DNA damage in cancer cells – we push them toward the curve hopefully at a greater rate than healthy cells. If WEE1 is there, cancer cells can round the curve. Without it, they flip.”

“I am optimistic that this will eventually lead to a therapeutic regimen that allows us to target AML cells that have escaped conventional therapies,” said Dr. Porter. “In light of
these data, we are already early in the clinical trial planning process.”

Related Links:

University of Colorado School of Medicine



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.